Polycystic Ovarian Syndrome (PCOS) Therapeutics
Market to Grow due to Rising Occurrence of
Diabetes and Obesity Globally
A new market research report by Transparency Market Research, titled “Polycystic Ovarian
Syndrome (PCOS) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends
and Forecast, 2013 - 2019”, presents an extensive evaluation of this market both in terms of
volume and revenue. The competition within the market has been assessed by employing the
Porter’s five forces model. The study also presents an in-depth analysis of the governing factors,
macro-economic indicators, and the prevailing market trends. The market attractiveness of all
segments within the market for PCOS therapeutics has also been presented.
Polycystic ovarian syndrome (PCOS) is a type of endocrine system disorder common amongst
females between the age of 18 and 44 years. PCOS comprises a set of symptoms caused owing to
the elevated male hormone testosterone within women. Symptoms and signs of PCOS comprise
heavy, irregular, or no menstruation; excess hair on body or face; acne; pelvic pain; difficulty in
conceiving; velvety skin, among others. PCOS can be caused owing to a number of
environmental and genetic factors. The market for PCOS therapeutics is segmented into
contraceptive drugs, anti-androgen drugs, ovulation stimulants, diabetes treatment drugs, dietary
supplements, and cancer treatment drugs.
According to the report, the market for PCOS therapeutics is growing owing to a number of
factors. Some of the major factors driving the growth of the market include the rising occurrence
of diabetes, the rising hormonal and genetic disorders, and the increasing obese population.
Amongst these, PCOS is most common in obese and diabetic women. Furthermore, the
increasing count of drugs in clinical trials and their expected commercialization in the coming
years will also propel the growth of the market, as per this study.
On the other...